2022
DOI: 10.3892/etm.2022.11620
|View full text |Cite
|
Sign up to set email alerts
|

Chemerin promotes MAPK/ERK activation to induce inflammatory factor production in rat synoviocytes

Abstract: Chemerin is a chemokine found in adipose tissue that specifically binds to the G protein-coupled receptor, chemokine-like receptor 1, and acts as a chemoattractant for macrophages and dendritic cells. Chemerin levels in the synovial fluid are associated with disease severity in patients with osteoarthritis (OA). However, to the best of our knowledge, the specific mechanism through which chemerin exerts its effects in OA remains unclear. The present study aimed to investigate the underlying mechanism of chemeri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…For example, leptin, chemerin, resistin, visfatin and lipocalin-2 are now believed to have detrimental effects on joint tissue. However, others were reported to maintain cartilage integrity and reduce osteophyte formation, such as progranulin, vaspin and omentin-1 [ 38 , 39 , 95 , [100] , [101] , [102] , [103] , [104] , [105] ]. Accordingly, adipokines have emerged as potential candidates to link obesity with OA which may also serve as putative targets for disease-modifying OA drugs, especially for obese patients [ 95 , 96 , 99 , 103 , 106 ].…”
Section: Obesity-oa Interplay Beyond Mechanical Loadingmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, leptin, chemerin, resistin, visfatin and lipocalin-2 are now believed to have detrimental effects on joint tissue. However, others were reported to maintain cartilage integrity and reduce osteophyte formation, such as progranulin, vaspin and omentin-1 [ 38 , 39 , 95 , [100] , [101] , [102] , [103] , [104] , [105] ]. Accordingly, adipokines have emerged as potential candidates to link obesity with OA which may also serve as putative targets for disease-modifying OA drugs, especially for obese patients [ 95 , 96 , 99 , 103 , 106 ].…”
Section: Obesity-oa Interplay Beyond Mechanical Loadingmentioning
confidence: 99%
“… • Activates TLR4 and Akt/ERK pathways. Eisinger et al [ 113 ] Ma et al [ 114 ] Wang et al [ 104 ] Resistin • Binds to TLR4 and CAP1 receptors, which activate p38-MAPK and NF-κB, and C/EBP-β signalling pathways. • Promotes the release of pro-inflammatory cytokines/chemokines and degradative markers such as IL-6, IL-1α, IL-1β, TNF-α, CCL2, CCL3, CCL3L1, CCL4, CCL5, CCL8, CCL20, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL8 (IL-8), CX3CL1, MMP-1, MMP-13, and ADAMTS-4.…”
Section: Obesity-oa Interplay Beyond Mechanical Loadingmentioning
confidence: 99%